A Study of Efficacy and Safety With the Transdermal Contraceptive System Versus Triphasil.

PHASE3CompletedINTERVENTIONAL

Enrollment

1,494

Participants

Timeline

Start Date

January 31, 1997

Study Completion Date

March 31, 1999

Conditions

ContraceptionFemale Contraception

Interventions

DRUG

norelgestromin + ethinyl estradiol; triphasil.

All Listed Sponsors

lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00236795 - A Study of Efficacy and Safety With the Transdermal Contraceptive System Versus Triphasil. | Biotech Hunter | Biotech Hunter